Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03654807 · ClinicalTrials.gov registry record · NA
The Effect of Walking on Frailty
A NA study of Frailty, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT03654807: Completed NA study of Frailty, sponsored by Northwestern University.
NCT03654807 is a NA study of Frailty that has completed, run by Northwestern University. The registered enrollment target is 156 participants, below the 1,503-participant average among 48 other Frailty trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03654807, a NA study of Frailty, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effect of walking intensity on both frailty category (i.e., frail, pre-frail, and nonfrail) and frailty score as a continuous outcome on the SHARE-FI (frailty instrument). As well as test the effect of walking intensity on mobility, physical function, balance, and total Physical Activity.
Primary Outcome
SHARE-FI which assesses fatigue, appetite, weakness, walking difficulties, and low physical activity
Conditions Studied
Interventions
- BEHAVIORAL High Intensity Walking
- BEHAVIORAL Casual Speed Walking
Study Locations (1)
Illinois
- Northwestern Univiersity Department of Physical Therapy and Human Movement Sciences - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2018-11-26 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
What the finished NCT03654807 record still lists
NCT03654807 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 1,503-participant average among 48 other Frailty trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Frailty appearing as the primary indexed condition, and to 2 interventions - of which High Intensity Walking is the first listed.
NCT03654807 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03654807 about?
NCT03654807 is a clinical study titled "The Effect of Walking on Frailty". The purpose of this study is to test the effect of walking intensity on both frailty category (i.e., frail, pre-frail, and nonfrail) and frailty score as a continuous outcome on the SHARE-FI (frailty instrument). As well as test the effect of walking intensity on mobility, physical function, balance...
What is the current status of trial NCT03654807?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2018-11-26. Estimated completion is 2024-05-31.
What conditions does trial NCT03654807 study?
This clinical trial studies the following conditions: Frailty.
What interventions are being tested in trial NCT03654807?
The interventions under investigation include: High Intensity Walking (BEHAVIORAL), Casual Speed Walking (BEHAVIORAL).
Who is sponsoring clinical trial NCT03654807?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03654807 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Frailty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03654807's enrollment target sits among peer trials
156 10th of 48 higher than 39 of 48 other Frailty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Frailty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings
RECRUITING · NA
-
Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
Meal Delivery and Exercise
RECRUITING · NA
-
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI